Nuvation Bio Inc. (NYSE:NUVB) is one of the top strong buy stocks under $5 to buy now. In a report released on August 8, Robert Burns from H.C. Wainwright reiterated a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) with a price target of $10.00.
A close-up of researchers, carefully studying a biopharmaceutical compound in a laboratory.
Similarly, in a report released on August 7, Leonid Timashev from RBC Capital reiterated a Buy rating on Nuvation Bio Inc. and set a price target of $7.00.
The same day, David Nierengarten from Wedbush also maintained a Buy rating on Nuvation Bio Inc. with a price target of $6.00. The stock’s median price target of $2.90 implies an upside of 141.38% from current levels.
Nuvation Bio is a biopharmaceutical company that develops therapeutic and differentiated candidates to tackle the gaps in oncology.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
